Genenta Science S.p.A. Comprehensive Income
Genenta Science S.p.A. (GNTA) reported Comprehensive Income of -EUR 6.45 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-04-01
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|
| 2025-12-31 | -6.45M EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | -3.78M EUR 6-K · filed 2025-10-10 | |
| 2024-12-31 | -9.05M EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | -4.12M EUR 6-K · filed 2025-10-10 | |
| 2023-12-31 | -11.45M EUR 20-F · filed 2026-04-01 | |
| 2023-06-30 | -6.76M EUR 6-K · filed 2024-10-29 | |
| 2022-12-31 | -8.48M EUR 20-F · filed 2025-03-28 | |
| 2022-06-30 | -2.11M EUR 6-K · filed 2023-10-20 | |
| 2021-12-31 | -5.53M EUR 20-F · filed 2024-03-29 | |
| 2021-06-30 | -4.05M EUR 6-K · filed 2022-10-25 | |
| 2020-12-31 | -5.59M EUR 20-F · filed 2023-04-21 | |
| 2019-12-31 | -4.60M EUR 20-F · filed 2022-05-02 |